Cryotherapy as an alternative therapy for the treatment of recalcitrant alopecia areata

Iranian Journal of Dermatology

Volumn 16, Issue 64, 2013, Pages 49-52

  Radmanesh, Mohammad ^a   Azar Beig, Mohsen ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alopecia areata; Alopecia totalis; Cryotherapy; Treatment

Indexed keywords

EID: 84885632806     PISSN: 0021082X     EISSN: 27170721     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ito T, Ito N, Saatoff M, et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 2008;128:1196-206.
2. Zhang Z, Xu SX, Zhang FY, et al. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients. Arch Dermatol Res 2009;301:167-73.
3. Kurtev A, Iliev E. Thyroid autoimmunity in children and adolescents with alopecia areata. Int J Dermatol 2005;44:457-61.
4. Galbraith GM, Thiers BH, Vasily DB, Fudenberg HH. Immunological profiles in alopecia areata. Br J Dermatol 1984;110:163-70.
5. Seyrafi H, Akhiani M, Abbasi H, et al. Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol 2005;5:11.
6. Nanda A, Alsaleh QA, Al-Hasawi, Al-Muzairai I. Thyroid function, autoantibodies, and HLA tissue typing in children with alopecia areata. Pediatr Dermatol 2002;19:486-91.
7. Friedmann PS. Alopecia areata and auto-immunity. Br J Dermatol 1981;105: 153-7.
8. th edition, Philadelphia, Williams and Wilkins 2009;474.
9. Tobin DJ, Hann SK, Song MS, Bystryn JC. Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch Dermatol 1997;133:57-61.
10. Gupta AK, Ellis CN, Cooper KD, et al. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 1990; 22(2 Pt 1):242-50.
11. Lie Y, Zhang JM, Liao DY, et al. Effect of superficial hypothermic cryotherapy with liquid nitrogen on alopecia areata. Arch Dermatol 1991; 127: 1851-2.
12. Morita K, Nakamura M, Nagamachi M, et al. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies. J Dermatol 2002; 29:661-4.
13. Cohen RL, Alves ME, Weiss VC, et al. Direct effects of minoxidil on epidermal cells in culture. J Invest Dermatol 1984;82:90-3.
14. Fiedler-Weiss VC. Potential mechanisms of minoxilinduced hair growth in alopecia areata. J Am Acad Dermatol 1987; 16(3 Pt 2):653-6.
15. Fiedler VC, Buys CM. Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment. Dermatologica 1987;175Suppl 2:29-35.
16. Christoph T, Muller-Rover S, Audring H, et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 2000;142:862-73.
17. Majewski BB, Koh MS, Taylor DR, et al. Increased ratio of helper to suppressor T cells in alopecia areata. Br J Dermatol 1984;110:171-5.
18. Ledesma GN, York KK. Suppressor cell decrease in alopecia areata. Arch Dermatol Res 1982; 274:1-8.
19. Tobin DJ, Fenton DA, Kendall MD. Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata. J Invest Dermatol 1990; 94: 803-7.
20. Kohchiyama A, Hatamochi A, Ueki H. Increased number of OKT6-positive dendritic cells in the hair follicles of patients with alopecia areata. Dermatologica 1985;171:327-31.
21. Heffer LC, Kastman AL, Jacobsson Ekman G, et al. Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata. Br J Dermatol 2002;147: 222-9.
22. Tobin DJ. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc 2003;8:176-81.
23. Tobin DJ, Orentreich N, Fenton DA, Bystryn JC. Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994;102:721-4.